Summary

The global Custom Antibody Services market size is predicted to grow from US$ 2360 million in 2025 to US$ 4474 million in 2032; it is expected to grow at a CAGR of 9.8% from 2026 to 2032.
Custom Antibody Services are outsourced, project-based technical services for the discovery, development, engineering, expression, production, purification, modification, characterization, and validation of antibodies designed for specific customer requirements. The research scope covers antigen and immunogen design, animal immunization, hybridoma development, single-B-cell screening, phage and yeast display, antibody sequencing, humanization, affinity maturation, Fc engineering, format conversion, recombinant expression, conjugation, analytical testing, and application-specific validation. Principal deliverables include antiserum, hybridoma clones, antibody sequences, recombinant antibodies, purified or labeled antibody batches, assay-ready antibody pairs, and supporting analytical data. Key technical indicators include specificity, affinity, titer, purity, yield, sequence accuracy, functional activity, lot-to-lot consistency, and performance in ELISA, Western blotting, immunohistochemistry, flow cytometry, and related assays. Custom Antibody Services primarily support research applications, in vitro diagnostic development, and therapeutic antibody development, with customers comprising biopharmaceutical companies, diagnostic companies and clinical laboratories, universities, and research institutions. This study focuses on customized antibody projects provided to external customers under fee-for-service, milestone-based, or integrated project contracts.
Key Findings
Research applications remained the broadest demand base for Custom Antibody Services
North America remained the largest regional market for Custom Antibody Services
Market Trends
Custom Antibody Services are shifting from conventional animal immunization and hybridoma-based production toward sequence-defined, recombinant, high-throughput, and application-validated service models. Customers increasingly require antibody sequences, recombinant expression records, functional screening data, and reproducible production rather than accepting purified antibody material as the sole deliverable. Single-B-cell screening, phage and yeast display, microfluidic screening, next-generation sequencing, and computational sequence analysis are shortening discovery cycles and increasing the probability of identifying differentiated binders. Demand is also moving toward difficult antigens, post-translational modifications, membrane proteins, anti-idiotypic antibodies, nanobodies, bispecific formats, and antibodies optimized for diagnostic or therapeutic development. Integrated service capabilities now extend from antigen design through production, purification, and validation, while therapeutic-oriented platforms add humanization, affinity maturation, developability assessment, and format engineering. These changes are reflected in the expanding workflows offered by Thermo Fisher Scientific, GenScript, and WuXi Biologics. Long-term competition will increasingly depend on data quality, turnaround time, platform success rates, sequence traceability, and the ability to transfer an antibody from discovery into downstream assays or therapeutic development.
Market Dynamics
Drivers
Expansion in biomedical research, biologic drug pipelines, biomarker discovery, precision diagnostics, and immunoassay development is sustaining demand for Custom Antibody Services. Outsourcing enables customers to access specialized animal facilities, antibody libraries, single-cell platforms, expression systems, analytical instruments, and experienced scientific teams without maintaining these capabilities internally. Pharmaceutical and biotechnology companies are also using external providers to run parallel discovery campaigns, screen more targets, and shorten early development timelines. For academic and diagnostic customers, outsourcing converts fixed laboratory investment into project expenditure and provides access to standardized production and validation processes. Increasing requirements for sequence-defined antibodies, assay reproducibility, and application-specific validation further support the transition from informal laboratory antibody generation to professional Custom Antibody Services providers.
Restraints
Custom Antibody Services remain constrained by biological uncertainty, variable antigen immunogenicity, lengthy project cycles, and the possibility that a project may not produce antibodies meeting the required specificity or functional performance. Difficult membrane proteins, highly conserved targets, toxic antigens, and modification-specific epitopes can require repeated antigen redesign, alternative host species, or multiple discovery platforms, increasing both cost and delivery time. Pricing is also difficult to standardize because project value depends on antigen complexity, antibody format, screening depth, expression scale, validation requirements, and intellectual-property terms. Budget pressure among academic laboratories and smaller biotechnology companies can delay projects or favor lower-priced, limited-scope packages. In therapeutic development, higher documentation, biosafety, quality, and developability requirements raise the cost of service delivery.
Opportunities
The strongest opportunities in Custom Antibody Services are emerging in specialized antibodies and integrated development workflows. Nanobodies, bispecific and multispecific antibodies, antibody fragments, anti-idiotypic antibodies, recombinant rabbit antibodies, and antibodies against post-translational modifications require capabilities that many customers cannot efficiently establish in-house. Diagnostic companies need matched antibody pairs, conjugated antibodies, and application-validated reagents for immunoassays, pathology, and point-of-care testing. Therapeutic developers increasingly require discovery programs that can proceed directly into humanization, affinity maturation, developability assessment, cell-line development, and preclinical testing. Custom Antibody Services providers able to connect antibody discovery with assay development or therapeutic development can capture a larger share of project value and establish longer customer relationships.
Challenges
The Custom Antibody Services industry must manage reproducibility, sequence ownership, freedom-to-operate, data integrity, and quality consistency across discovery, production, and validation workflows. Customers increasingly expect antibodies to perform across multiple applications, yet performance in one assay does not guarantee suitability in another, creating a need for more extensive validation and clearer acceptance criteria. Providers must also balance rapid turnaround with scientific rigor while maintaining animal welfare compliance, biosafety controls, secure handling of customer sequences, and reliable sample traceability. Competition from internal pharmaceutical discovery teams, automated laboratory platforms, synthetic antibody libraries, and lower-cost regional providers may compress prices for routine services. The ability to recruit experienced scientists and maintain specialized platform utilization is another long-term operational challenge.
Industry Chain Analysis
The upstream chain for Custom Antibody Services comprises synthetic peptides, recombinant antigens, plasmids, expression vectors, host cells, laboratory animals, cell culture media, purification resins, enzymes, labels, analytical reagents, laboratory instruments, sequencing platforms, and bioinformatics tools. Antigen quality and design directly influence immunization, screening efficiency, antibody specificity, and downstream project economics. The midstream service layer converts these inputs into customized deliverables through antigen preparation, antibody discovery, clone screening, sequence recovery, engineering, recombinant expression, purification, conjugation, characterization, and application validation. Platform integration reduces sample transfers and project delays, while proprietary libraries, optimized expression systems, and accumulated screening data raise technical barriers and support premium pricing.
Downstream customers include biopharmaceutical companies, diagnostic developers, clinical laboratories, universities, research institutes, and other life-science organizations. Value is created by reducing discovery time, improving the probability of obtaining usable antibodies, generating reproducible sequence-defined materials, and preparing candidates for downstream assays or therapeutic programs. Major costs include scientific labor, animal and cell-culture operations, consumables, sequencing and analytical testing, facility depreciation, quality systems, and business development. Routine immunization and purification projects face greater price competition, whereas specialized discovery, engineering, functional screening, and integrated therapeutic-development projects generally provide stronger customer retention and higher profit potential.
Segment Insights
By service type, antibody discovery and development services form the entry point of the Custom Antibody Services project pipeline and generate follow-on demand for engineering, expression, purification, characterization, and validation. Antibody expression, production, and purification account for substantial project volume because they serve both newly discovered antibodies and customer-supplied sequences or hybridoma cell lines. Antibody engineering and modification services command higher project values when they involve humanization, affinity maturation, Fc optimization, format conversion, labeling, or conjugation. Characterization and validation are becoming more important as customers require quantitative evidence of affinity, specificity, purity, biological activity, and performance in intended applications.
By antibody type, polyclonal antibody production remains attractive for rapid, cost-sensitive research projects, while monoclonal antibody production provides greater specificity, reproducibility, and long-term supply consistency. Specialized antibody development represents the principal value-upgrading direction, covering nanobodies, bispecific and multispecific antibodies, antibody fragments, fusion formats, anti-idiotypic antibodies, and other technically demanding products. By application, research remains the broadest project base; in vitro diagnostics emphasize matched pairs, lot consistency, supply continuity, and assay validation; therapeutic antibody development generates more complex and higher-value contracts but requires longer cycles and stricter technical documentation.
Downstream Market Opportunities
Biopharmaceutical companies represent the most valuable downstream opportunity for Custom Antibody Services because antibody discovery projects can extend into optimization, developability assessment, preclinical evaluation, and subsequent development services. Diagnostic companies and clinical laboratories require antibodies with stable lot performance, high specificity, reliable conjugation, and verified performance in defined assay systems, creating recurring production and validation demand after successful development. Universities and research institutions remain an important source of novel targets and early-stage projects, although procurement is more price-sensitive and fragmented. Emerging opportunities include companion diagnostics, spatial biology, multiplex immunoassays, cell and gene therapy analytics, antibody-drug conjugate research, pharmacokinetic assays, immunogenicity testing, and antibodies targeting newly characterized biomarkers.
Regional Insights
North America remains the largest regional market for Custom Antibody Services, supported by its concentration of pharmaceutical and biotechnology companies, extensive biomedical research activity, developed outsourcing practices, and strong demand for therapeutic antibody discovery and specialized analytical services. The market supports both diversified life-science suppliers and specialized antibody discovery companies, with customers generally placing greater emphasis on platform quality, intellectual-property protection, project management, and regulatory readiness. Europe has established capabilities in recombinant antibody discovery, display technologies, antibody engineering, diagnostics, and specialized therapeutic research, with additional emphasis on reproducibility and non-animal technology alternatives.
Asia-Pacific is the principal expansion region, led by increasing biopharmaceutical research, diagnostic localization, research funding, and the development of integrated biotechnology service platforms. China has built a broad supply base spanning antigen preparation, antibody production, recombinant expression, high-throughput screening, therapeutic discovery, and analytical testing. Its competitive position is supported by engineering capacity, turnaround time, flexible project design, and cost-efficient laboratory operations. Japan and South Korea contribute demand from established pharmaceutical, diagnostic, and academic research systems, while other emerging Asian markets primarily access Custom Antibody Services through cross-border contracts and regional sales channels.
Competitive Landscape Analysis
The Custom Antibody Services market is fragmented across diversified life-science groups, antibody-focused service specialists, therapeutic discovery organizations, and regional biotechnology providers. Thermo Fisher Scientific, Bio-Rad, Danaher through Abcam, and Bio-Techne through R&D Systems benefit from established customer channels, broad reagent portfolios, technical support networks, and the ability to combine customized services with related laboratory products. Charles River Laboratories, WuXi Biologics, Abzena, FairJourney Biologics, Fusion Antibodies, and other therapeutic-oriented providers compete through discovery platforms, antibody engineering, developability capabilities, and integration with downstream drug development. GenScript, Sino Biological, ABclonal, CUSABIO, Sanyou Biopharmaceuticals, Biointron, and other China-based providers combine scalable laboratory operations with competitive turnaround times and broad technical coverage. Specialized companies such as Rockland Immunochemicals, Antibody Solutions, ProteoGenix, Icosagen, ProMab Biotechnologies, Innovagen, Randox, and Capra Science differentiate through selected antibody formats, host species, diagnostic applications, or customized workflows. Competition is moving beyond basic price and delivery time toward discovery success, application validation, sequence ownership, data quality, technical communication, and the ability to support customers across multiple development stages.
Report Scope
LPI (LP Information)' newest research report, the “Custom Antibody Services Industry Forecast” looks at past sales and reviews total world Custom Antibody Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Custom Antibody Services sales for 2026 through 2032. With Custom Antibody Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Antibody Services industry.
This Insight Report provides a comprehensive analysis of the global Custom Antibody Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Antibody Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Antibody Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Antibody Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Antibody Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Custom Antibody Services market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
Antibody Discovery and Development Services
Antibody Engineering and Modification Services
Antibody Expression, Production and Purification Services
Antibody Characterization and Validation Services
Segmentation by Antibody Type:
Polyclonal Antibody Production
Monoclonal Antibody Production
Specialized Antibody Development
Others
Segmentation by End User:
Biopharmaceutical Companies
Diagnostic Companies and Clinical Laboratories
Academic and Research Institutions
Others
Segmentation by Application:
Research Applications
In Vitro Diagnostic Applications
Therapeutic Antibody Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation, Through Abcam Ltd.
Bio-Techne Corporation, Through R&D Systems
Charles River Laboratories International, Inc.
Creative Biolabs
ProteoGenix SAS
Rockland Immunochemicals, Inc.
Antibody Solutions
FairJourney Biologics S.A.
Fusion Antibodies plc
Icosagen AS
ProMab Biotechnologies, Inc.
Abzena plc
Inotiv, Inc.
Randox Laboratories Ltd.
Innovagen AB
Genesee Scientific, Through ProSci LLC
Labcorp Holdings Inc.
Capra Science Antibodies AB
Pacific Immunology Corp.
Enzo Biochem, Inc.
Genscript Biotech Corporation
Sino Biological Inc.
ABclonal Technology Co., Ltd.
CUSABIO
Hangzhou HuaAn Biotechnology Co., Ltd.
Sanyou Biopharmaceuticals Co., Ltd.
Biointron Biological Inc.
Novoprotein Scientific Inc.
Fapon Biotech Inc.
WuXi Biologics
Wuhan Boster Biological Technology Co., Ltd.
GL Biochem Shanghai Ltd.
Elabscience Biotechnology Co., Ltd.

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Custom Antibody Services Market Size (2021-2032)
2.1.2 Custom Antibody Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Custom Antibody Services by Country/Region (2021, 2025 & 2032)
2.2 Custom Antibody Services Segment by Type
2.2.1 Antibody Discovery and Development Services
2.2.2 Antibody Engineering and Modification Services
2.2.3 Antibody Expression, Production and Purification Services
2.2.4 Antibody Characterization and Validation Services
2.2.5 Custom Antibody Services Market Size by Type
2.2.5.1 Custom Antibody Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Custom Antibody Services Market Size Market Share by Type (2021-2026)
2.3 Custom Antibody Services Segment by Antibody Type
2.3.1 Polyclonal Antibody Production
2.3.2 Monoclonal Antibody Production
2.3.3 Specialized Antibody Development
2.3.4 Others
2.3.5 Custom Antibody Services Market Size by Antibody Type
2.3.5.1 Custom Antibody Services Market Size CAGR by Antibody Type (2021 VS 2025 VS 2032)
2.3.5.2 Global Custom Antibody Services Market Size Market Share by Antibody Type (2021-2026)
2.4 Custom Antibody Services Segment by End User
2.4.1 Biopharmaceutical Companies
2.4.2 Diagnostic Companies and Clinical Laboratories
2.4.3 Academic and Research Institutions
2.4.4 Others
2.4.5 Custom Antibody Services Market Size by End User
2.4.5.1 Custom Antibody Services Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.4.5.2 Global Custom Antibody Services Market Size Market Share by End User (2021-2026)
2.5 Custom Antibody Services Segment by Application
2.5.1 Research Applications
2.5.2 In Vitro Diagnostic Applications
2.5.3 Therapeutic Antibody Development
2.5.4 Others
2.5.5 Custom Antibody Services Market Size by Application
2.5.5.1 Custom Antibody Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Custom Antibody Services Market Size Market Share by Application (2021-2026)

3 Custom Antibody Services Market Size by Player
3.1 Custom Antibody Services Market Size Market Share by Player
3.1.1 Global Custom Antibody Services Revenue by Player (2021-2026)
3.1.2 Global Custom Antibody Services Revenue Market Share by Player (2021-2026)
3.2 Global Custom Antibody Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Custom Antibody Services by Region
4.1 Custom Antibody Services Market Size by Region (2021-2026)
4.2 Global Custom Antibody Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Custom Antibody Services Market Size Growth (2021-2026)
4.4 APAC Custom Antibody Services Market Size Growth (2021-2026)
4.5 Europe Custom Antibody Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Custom Antibody Services Market Size Growth (2021-2026)

5 Americas
5.1 Americas Custom Antibody Services Market Size by Country (2021-2026)
5.2 Americas Custom Antibody Services Market Size by Type (2021-2026)
5.3 Americas Custom Antibody Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Custom Antibody Services Market Size by Region (2021-2026)
6.2 APAC Custom Antibody Services Market Size by Type (2021-2026)
6.3 APAC Custom Antibody Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Custom Antibody Services Market Size by Country (2021-2026)
7.2 Europe Custom Antibody Services Market Size by Type (2021-2026)
7.3 Europe Custom Antibody Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Custom Antibody Services by Region (2021-2026)
8.2 Middle East & Africa Custom Antibody Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Custom Antibody Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Custom Antibody Services Market Forecast
10.1 Global Custom Antibody Services Forecast by Region (2027-2032)
10.1.1 Global Custom Antibody Services Forecast by Region (2027-2032)
10.1.2 Americas Custom Antibody Services Forecast
10.1.3 APAC Custom Antibody Services Forecast
10.1.4 Europe Custom Antibody Services Forecast
10.1.5 Middle East & Africa Custom Antibody Services Forecast
10.2 Americas Custom Antibody Services Forecast by Country (2027-2032)
10.2.1 United States Market Custom Antibody Services Forecast
10.2.2 Canada Market Custom Antibody Services Forecast
10.2.3 Mexico Market Custom Antibody Services Forecast
10.2.4 Brazil Market Custom Antibody Services Forecast
10.3 APAC Custom Antibody Services Forecast by Region (2027-2032)
10.3.1 China Custom Antibody Services Market Forecast
10.3.2 Japan Market Custom Antibody Services Forecast
10.3.3 Korea Market Custom Antibody Services Forecast
10.3.4 Southeast Asia Market Custom Antibody Services Forecast
10.3.5 India Market Custom Antibody Services Forecast
10.3.6 Australia Market Custom Antibody Services Forecast
10.4 Europe Custom Antibody Services Forecast by Country (2027-2032)
10.4.1 Germany Market Custom Antibody Services Forecast
10.4.2 France Market Custom Antibody Services Forecast
10.4.3 UK Market Custom Antibody Services Forecast
10.4.4 Italy Market Custom Antibody Services Forecast
10.4.5 Russia Market Custom Antibody Services Forecast
10.5 Middle East & Africa Custom Antibody Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Custom Antibody Services Forecast
10.5.2 South Africa Market Custom Antibody Services Forecast
10.5.3 Israel Market Custom Antibody Services Forecast
10.5.4 Turkey Market Custom Antibody Services Forecast
10.6 Global Custom Antibody Services Forecast by Type (2027-2032)
10.7 Global Custom Antibody Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Custom Antibody Services Forecast

11 Key Players Analysis
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Information
11.1.2 Thermo Fisher Scientific Inc. Custom Antibody Services Product Offered
11.1.3 Thermo Fisher Scientific Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Inc. Main Business Overview
11.1.5 Thermo Fisher Scientific Inc. Latest Developments
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Information
11.2.2 Bio-Rad Laboratories, Inc. Custom Antibody Services Product Offered
11.2.3 Bio-Rad Laboratories, Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.2.5 Bio-Rad Laboratories, Inc. Latest Developments
11.3 Danaher Corporation, Through Abcam Ltd.
11.3.1 Danaher Corporation, Through Abcam Ltd. Company Information
11.3.2 Danaher Corporation, Through Abcam Ltd. Custom Antibody Services Product Offered
11.3.3 Danaher Corporation, Through Abcam Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Danaher Corporation, Through Abcam Ltd. Main Business Overview
11.3.5 Danaher Corporation, Through Abcam Ltd. Latest Developments
11.4 Bio-Techne Corporation, Through R&D Systems
11.4.1 Bio-Techne Corporation, Through R&D Systems Company Information
11.4.2 Bio-Techne Corporation, Through R&D Systems Custom Antibody Services Product Offered
11.4.3 Bio-Techne Corporation, Through R&D Systems Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Techne Corporation, Through R&D Systems Main Business Overview
11.4.5 Bio-Techne Corporation, Through R&D Systems Latest Developments
11.5 Charles River Laboratories International, Inc.
11.5.1 Charles River Laboratories International, Inc. Company Information
11.5.2 Charles River Laboratories International, Inc. Custom Antibody Services Product Offered
11.5.3 Charles River Laboratories International, Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Charles River Laboratories International, Inc. Main Business Overview
11.5.5 Charles River Laboratories International, Inc. Latest Developments
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Information
11.6.2 Creative Biolabs Custom Antibody Services Product Offered
11.6.3 Creative Biolabs Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Creative Biolabs Main Business Overview
11.6.5 Creative Biolabs Latest Developments
11.7 ProteoGenix SAS
11.7.1 ProteoGenix SAS Company Information
11.7.2 ProteoGenix SAS Custom Antibody Services Product Offered
11.7.3 ProteoGenix SAS Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ProteoGenix SAS Main Business Overview
11.7.5 ProteoGenix SAS Latest Developments
11.8 Rockland Immunochemicals, Inc.
11.8.1 Rockland Immunochemicals, Inc. Company Information
11.8.2 Rockland Immunochemicals, Inc. Custom Antibody Services Product Offered
11.8.3 Rockland Immunochemicals, Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Rockland Immunochemicals, Inc. Main Business Overview
11.8.5 Rockland Immunochemicals, Inc. Latest Developments
11.9 Antibody Solutions
11.9.1 Antibody Solutions Company Information
11.9.2 Antibody Solutions Custom Antibody Services Product Offered
11.9.3 Antibody Solutions Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Antibody Solutions Main Business Overview
11.9.5 Antibody Solutions Latest Developments
11.10 FairJourney Biologics S.A.
11.10.1 FairJourney Biologics S.A. Company Information
11.10.2 FairJourney Biologics S.A. Custom Antibody Services Product Offered
11.10.3 FairJourney Biologics S.A. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 FairJourney Biologics S.A. Main Business Overview
11.10.5 FairJourney Biologics S.A. Latest Developments
11.11 Fusion Antibodies plc
11.11.1 Fusion Antibodies plc Company Information
11.11.2 Fusion Antibodies plc Custom Antibody Services Product Offered
11.11.3 Fusion Antibodies plc Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Fusion Antibodies plc Main Business Overview
11.11.5 Fusion Antibodies plc Latest Developments
11.12 Icosagen AS
11.12.1 Icosagen AS Company Information
11.12.2 Icosagen AS Custom Antibody Services Product Offered
11.12.3 Icosagen AS Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Icosagen AS Main Business Overview
11.12.5 Icosagen AS Latest Developments
11.13 ProMab Biotechnologies, Inc.
11.13.1 ProMab Biotechnologies, Inc. Company Information
11.13.2 ProMab Biotechnologies, Inc. Custom Antibody Services Product Offered
11.13.3 ProMab Biotechnologies, Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 ProMab Biotechnologies, Inc. Main Business Overview
11.13.5 ProMab Biotechnologies, Inc. Latest Developments
11.14 Abzena plc
11.14.1 Abzena plc Company Information
11.14.2 Abzena plc Custom Antibody Services Product Offered
11.14.3 Abzena plc Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Abzena plc Main Business Overview
11.14.5 Abzena plc Latest Developments
11.15 Inotiv, Inc.
11.15.1 Inotiv, Inc. Company Information
11.15.2 Inotiv, Inc. Custom Antibody Services Product Offered
11.15.3 Inotiv, Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Inotiv, Inc. Main Business Overview
11.15.5 Inotiv, Inc. Latest Developments
11.16 Randox Laboratories Ltd.
11.16.1 Randox Laboratories Ltd. Company Information
11.16.2 Randox Laboratories Ltd. Custom Antibody Services Product Offered
11.16.3 Randox Laboratories Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Randox Laboratories Ltd. Main Business Overview
11.16.5 Randox Laboratories Ltd. Latest Developments
11.17 Innovagen AB
11.17.1 Innovagen AB Company Information
11.17.2 Innovagen AB Custom Antibody Services Product Offered
11.17.3 Innovagen AB Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Innovagen AB Main Business Overview
11.17.5 Innovagen AB Latest Developments
11.18 Genesee Scientific, Through ProSci LLC
11.18.1 Genesee Scientific, Through ProSci LLC Company Information
11.18.2 Genesee Scientific, Through ProSci LLC Custom Antibody Services Product Offered
11.18.3 Genesee Scientific, Through ProSci LLC Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Genesee Scientific, Through ProSci LLC Main Business Overview
11.18.5 Genesee Scientific, Through ProSci LLC Latest Developments
11.19 Labcorp Holdings Inc.
11.19.1 Labcorp Holdings Inc. Company Information
11.19.2 Labcorp Holdings Inc. Custom Antibody Services Product Offered
11.19.3 Labcorp Holdings Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Labcorp Holdings Inc. Main Business Overview
11.19.5 Labcorp Holdings Inc. Latest Developments
11.20 Capra Science Antibodies AB
11.20.1 Capra Science Antibodies AB Company Information
11.20.2 Capra Science Antibodies AB Custom Antibody Services Product Offered
11.20.3 Capra Science Antibodies AB Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Capra Science Antibodies AB Main Business Overview
11.20.5 Capra Science Antibodies AB Latest Developments
11.21 Pacific Immunology Corp.
11.21.1 Pacific Immunology Corp. Company Information
11.21.2 Pacific Immunology Corp. Custom Antibody Services Product Offered
11.21.3 Pacific Immunology Corp. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Pacific Immunology Corp. Main Business Overview
11.21.5 Pacific Immunology Corp. Latest Developments
11.22 Enzo Biochem, Inc.
11.22.1 Enzo Biochem, Inc. Company Information
11.22.2 Enzo Biochem, Inc. Custom Antibody Services Product Offered
11.22.3 Enzo Biochem, Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Enzo Biochem, Inc. Main Business Overview
11.22.5 Enzo Biochem, Inc. Latest Developments
11.23 Genscript Biotech Corporation
11.23.1 Genscript Biotech Corporation Company Information
11.23.2 Genscript Biotech Corporation Custom Antibody Services Product Offered
11.23.3 Genscript Biotech Corporation Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Genscript Biotech Corporation Main Business Overview
11.23.5 Genscript Biotech Corporation Latest Developments
11.24 Sino Biological Inc.
11.24.1 Sino Biological Inc. Company Information
11.24.2 Sino Biological Inc. Custom Antibody Services Product Offered
11.24.3 Sino Biological Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Sino Biological Inc. Main Business Overview
11.24.5 Sino Biological Inc. Latest Developments
11.25 ABclonal Technology Co., Ltd.
11.25.1 ABclonal Technology Co., Ltd. Company Information
11.25.2 ABclonal Technology Co., Ltd. Custom Antibody Services Product Offered
11.25.3 ABclonal Technology Co., Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 ABclonal Technology Co., Ltd. Main Business Overview
11.25.5 ABclonal Technology Co., Ltd. Latest Developments
11.26 CUSABIO
11.26.1 CUSABIO Company Information
11.26.2 CUSABIO Custom Antibody Services Product Offered
11.26.3 CUSABIO Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 CUSABIO Main Business Overview
11.26.5 CUSABIO Latest Developments
11.27 Hangzhou HuaAn Biotechnology Co., Ltd.
11.27.1 Hangzhou HuaAn Biotechnology Co., Ltd. Company Information
11.27.2 Hangzhou HuaAn Biotechnology Co., Ltd. Custom Antibody Services Product Offered
11.27.3 Hangzhou HuaAn Biotechnology Co., Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Hangzhou HuaAn Biotechnology Co., Ltd. Main Business Overview
11.27.5 Hangzhou HuaAn Biotechnology Co., Ltd. Latest Developments
11.28 Sanyou Biopharmaceuticals Co., Ltd.
11.28.1 Sanyou Biopharmaceuticals Co., Ltd. Company Information
11.28.2 Sanyou Biopharmaceuticals Co., Ltd. Custom Antibody Services Product Offered
11.28.3 Sanyou Biopharmaceuticals Co., Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Sanyou Biopharmaceuticals Co., Ltd. Main Business Overview
11.28.5 Sanyou Biopharmaceuticals Co., Ltd. Latest Developments
11.29 Biointron Biological Inc.
11.29.1 Biointron Biological Inc. Company Information
11.29.2 Biointron Biological Inc. Custom Antibody Services Product Offered
11.29.3 Biointron Biological Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 Biointron Biological Inc. Main Business Overview
11.29.5 Biointron Biological Inc. Latest Developments
11.30 Novoprotein Scientific Inc.
11.30.1 Novoprotein Scientific Inc. Company Information
11.30.2 Novoprotein Scientific Inc. Custom Antibody Services Product Offered
11.30.3 Novoprotein Scientific Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Novoprotein Scientific Inc. Main Business Overview
11.30.5 Novoprotein Scientific Inc. Latest Developments
11.31 Fapon Biotech Inc.
11.31.1 Fapon Biotech Inc. Company Information
11.31.2 Fapon Biotech Inc. Custom Antibody Services Product Offered
11.31.3 Fapon Biotech Inc. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Fapon Biotech Inc. Main Business Overview
11.31.5 Fapon Biotech Inc. Latest Developments
11.32 WuXi Biologics
11.32.1 WuXi Biologics Company Information
11.32.2 WuXi Biologics Custom Antibody Services Product Offered
11.32.3 WuXi Biologics Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 WuXi Biologics Main Business Overview
11.32.5 WuXi Biologics Latest Developments
11.33 Wuhan Boster Biological Technology Co., Ltd.
11.33.1 Wuhan Boster Biological Technology Co., Ltd. Company Information
11.33.2 Wuhan Boster Biological Technology Co., Ltd. Custom Antibody Services Product Offered
11.33.3 Wuhan Boster Biological Technology Co., Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Wuhan Boster Biological Technology Co., Ltd. Main Business Overview
11.33.5 Wuhan Boster Biological Technology Co., Ltd. Latest Developments
11.34 GL Biochem Shanghai Ltd.
11.34.1 GL Biochem Shanghai Ltd. Company Information
11.34.2 GL Biochem Shanghai Ltd. Custom Antibody Services Product Offered
11.34.3 GL Biochem Shanghai Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 GL Biochem Shanghai Ltd. Main Business Overview
11.34.5 GL Biochem Shanghai Ltd. Latest Developments
11.35 Elabscience Biotechnology Co., Ltd.
11.35.1 Elabscience Biotechnology Co., Ltd. Company Information
11.35.2 Elabscience Biotechnology Co., Ltd. Custom Antibody Services Product Offered
11.35.3 Elabscience Biotechnology Co., Ltd. Custom Antibody Services Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Elabscience Biotechnology Co., Ltd. Main Business Overview
11.35.5 Elabscience Biotechnology Co., Ltd. Latest Developments

12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Custom Antibody Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Custom Antibody Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antibody Discovery and Development Services
Table 4. Major Players of Antibody Engineering and Modification Services
Table 5. Major Players of Antibody Expression, Production and Purification Services
Table 6. Major Players of Antibody Characterization and Validation Services
Table 7. Custom Antibody Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Custom Antibody Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Custom Antibody Services Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Polyclonal Antibody Production
Table 11. Major Players of Monoclonal Antibody Production
Table 12. Major Players of Specialized Antibody Development
Table 13. Major Players of Others
Table 14. Custom Antibody Services Market Size CAGR by Antibody Type (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Custom Antibody Services Market Size by Antibody Type (2021-2026) & ($ millions)
Table 16. Global Custom Antibody Services Market Size Market Share by Antibody Type (2021-2026)
Table 17. Major Players of Biopharmaceutical Companies
Table 18. Major Players of Diagnostic Companies and Clinical Laboratories
Table 19. Major Players of Academic and Research Institutions
Table 20. Major Players of Others
Table 21. Custom Antibody Services Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Custom Antibody Services Market Size by End User (2021-2026) & ($ millions)
Table 23. Global Custom Antibody Services Market Size Market Share by End User (2021-2026)
Table 24. Custom Antibody Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Custom Antibody Services Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Custom Antibody Services Market Size Market Share by Application (2021-2026)
Table 27. Global Custom Antibody Services Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Custom Antibody Services Revenue Market Share by Player (2021-2026)
Table 29. Custom Antibody Services Key Players Head office and Products Offered
Table 30. Custom Antibody Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Custom Antibody Services Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Custom Antibody Services Market Size Market Share by Region (2021-2026)
Table 35. Global Custom Antibody Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Custom Antibody Services Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Custom Antibody Services Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Custom Antibody Services Market Size Market Share by Country (2021-2026)
Table 39. Americas Custom Antibody Services Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Custom Antibody Services Market Size Market Share by Type (2021-2026)
Table 41. Americas Custom Antibody Services Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Custom Antibody Services Market Size Market Share by Application (2021-2026)
Table 43. APAC Custom Antibody Services Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Custom Antibody Services Market Size Market Share by Region (2021-2026)
Table 45. APAC Custom Antibody Services Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Custom Antibody Services Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Custom Antibody Services Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Custom Antibody Services Market Size Market Share by Country (2021-2026)
Table 49. Europe Custom Antibody Services Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Custom Antibody Services Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Custom Antibody Services Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Custom Antibody Services Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Custom Antibody Services Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Custom Antibody Services
Table 55. Key Market Challenges & Risks of Custom Antibody Services
Table 56. Key Industry Trends of Custom Antibody Services
Table 57. Global Custom Antibody Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Custom Antibody Services Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Custom Antibody Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Custom Antibody Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Thermo Fisher Scientific Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 62. Thermo Fisher Scientific Inc. Custom Antibody Services Product Offered
Table 63. Thermo Fisher Scientific Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Thermo Fisher Scientific Inc. Main Business
Table 65. Thermo Fisher Scientific Inc. Latest Developments
Table 66. Bio-Rad Laboratories, Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 67. Bio-Rad Laboratories, Inc. Custom Antibody Services Product Offered
Table 68. Bio-Rad Laboratories, Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Bio-Rad Laboratories, Inc. Main Business
Table 70. Bio-Rad Laboratories, Inc. Latest Developments
Table 71. Danaher Corporation, Through Abcam Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 72. Danaher Corporation, Through Abcam Ltd. Custom Antibody Services Product Offered
Table 73. Danaher Corporation, Through Abcam Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Danaher Corporation, Through Abcam Ltd. Main Business
Table 75. Danaher Corporation, Through Abcam Ltd. Latest Developments
Table 76. Bio-Techne Corporation, Through R&D Systems Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 77. Bio-Techne Corporation, Through R&D Systems Custom Antibody Services Product Offered
Table 78. Bio-Techne Corporation, Through R&D Systems Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Bio-Techne Corporation, Through R&D Systems Main Business
Table 80. Bio-Techne Corporation, Through R&D Systems Latest Developments
Table 81. Charles River Laboratories International, Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 82. Charles River Laboratories International, Inc. Custom Antibody Services Product Offered
Table 83. Charles River Laboratories International, Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Charles River Laboratories International, Inc. Main Business
Table 85. Charles River Laboratories International, Inc. Latest Developments
Table 86. Creative Biolabs Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 87. Creative Biolabs Custom Antibody Services Product Offered
Table 88. Creative Biolabs Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Creative Biolabs Main Business
Table 90. Creative Biolabs Latest Developments
Table 91. ProteoGenix SAS Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 92. ProteoGenix SAS Custom Antibody Services Product Offered
Table 93. ProteoGenix SAS Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. ProteoGenix SAS Main Business
Table 95. ProteoGenix SAS Latest Developments
Table 96. Rockland Immunochemicals, Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 97. Rockland Immunochemicals, Inc. Custom Antibody Services Product Offered
Table 98. Rockland Immunochemicals, Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Rockland Immunochemicals, Inc. Main Business
Table 100. Rockland Immunochemicals, Inc. Latest Developments
Table 101. Antibody Solutions Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 102. Antibody Solutions Custom Antibody Services Product Offered
Table 103. Antibody Solutions Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Antibody Solutions Main Business
Table 105. Antibody Solutions Latest Developments
Table 106. FairJourney Biologics S.A. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 107. FairJourney Biologics S.A. Custom Antibody Services Product Offered
Table 108. FairJourney Biologics S.A. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. FairJourney Biologics S.A. Main Business
Table 110. FairJourney Biologics S.A. Latest Developments
Table 111. Fusion Antibodies plc Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 112. Fusion Antibodies plc Custom Antibody Services Product Offered
Table 113. Fusion Antibodies plc Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Fusion Antibodies plc Main Business
Table 115. Fusion Antibodies plc Latest Developments
Table 116. Icosagen AS Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 117. Icosagen AS Custom Antibody Services Product Offered
Table 118. Icosagen AS Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Icosagen AS Main Business
Table 120. Icosagen AS Latest Developments
Table 121. ProMab Biotechnologies, Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 122. ProMab Biotechnologies, Inc. Custom Antibody Services Product Offered
Table 123. ProMab Biotechnologies, Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. ProMab Biotechnologies, Inc. Main Business
Table 125. ProMab Biotechnologies, Inc. Latest Developments
Table 126. Abzena plc Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 127. Abzena plc Custom Antibody Services Product Offered
Table 128. Abzena plc Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Abzena plc Main Business
Table 130. Abzena plc Latest Developments
Table 131. Inotiv, Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 132. Inotiv, Inc. Custom Antibody Services Product Offered
Table 133. Inotiv, Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Inotiv, Inc. Main Business
Table 135. Inotiv, Inc. Latest Developments
Table 136. Randox Laboratories Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 137. Randox Laboratories Ltd. Custom Antibody Services Product Offered
Table 138. Randox Laboratories Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Randox Laboratories Ltd. Main Business
Table 140. Randox Laboratories Ltd. Latest Developments
Table 141. Innovagen AB Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 142. Innovagen AB Custom Antibody Services Product Offered
Table 143. Innovagen AB Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Innovagen AB Main Business
Table 145. Innovagen AB Latest Developments
Table 146. Genesee Scientific, Through ProSci LLC Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 147. Genesee Scientific, Through ProSci LLC Custom Antibody Services Product Offered
Table 148. Genesee Scientific, Through ProSci LLC Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Genesee Scientific, Through ProSci LLC Main Business
Table 150. Genesee Scientific, Through ProSci LLC Latest Developments
Table 151. Labcorp Holdings Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 152. Labcorp Holdings Inc. Custom Antibody Services Product Offered
Table 153. Labcorp Holdings Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Labcorp Holdings Inc. Main Business
Table 155. Labcorp Holdings Inc. Latest Developments
Table 156. Capra Science Antibodies AB Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 157. Capra Science Antibodies AB Custom Antibody Services Product Offered
Table 158. Capra Science Antibodies AB Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Capra Science Antibodies AB Main Business
Table 160. Capra Science Antibodies AB Latest Developments
Table 161. Pacific Immunology Corp. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 162. Pacific Immunology Corp. Custom Antibody Services Product Offered
Table 163. Pacific Immunology Corp. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Pacific Immunology Corp. Main Business
Table 165. Pacific Immunology Corp. Latest Developments
Table 166. Enzo Biochem, Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 167. Enzo Biochem, Inc. Custom Antibody Services Product Offered
Table 168. Enzo Biochem, Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Enzo Biochem, Inc. Main Business
Table 170. Enzo Biochem, Inc. Latest Developments
Table 171. Genscript Biotech Corporation Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 172. Genscript Biotech Corporation Custom Antibody Services Product Offered
Table 173. Genscript Biotech Corporation Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. Genscript Biotech Corporation Main Business
Table 175. Genscript Biotech Corporation Latest Developments
Table 176. Sino Biological Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 177. Sino Biological Inc. Custom Antibody Services Product Offered
Table 178. Sino Biological Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. Sino Biological Inc. Main Business
Table 180. Sino Biological Inc. Latest Developments
Table 181. ABclonal Technology Co., Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 182. ABclonal Technology Co., Ltd. Custom Antibody Services Product Offered
Table 183. ABclonal Technology Co., Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. ABclonal Technology Co., Ltd. Main Business
Table 185. ABclonal Technology Co., Ltd. Latest Developments
Table 186. CUSABIO Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 187. CUSABIO Custom Antibody Services Product Offered
Table 188. CUSABIO Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. CUSABIO Main Business
Table 190. CUSABIO Latest Developments
Table 191. Hangzhou HuaAn Biotechnology Co., Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 192. Hangzhou HuaAn Biotechnology Co., Ltd. Custom Antibody Services Product Offered
Table 193. Hangzhou HuaAn Biotechnology Co., Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 194. Hangzhou HuaAn Biotechnology Co., Ltd. Main Business
Table 195. Hangzhou HuaAn Biotechnology Co., Ltd. Latest Developments
Table 196. Sanyou Biopharmaceuticals Co., Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 197. Sanyou Biopharmaceuticals Co., Ltd. Custom Antibody Services Product Offered
Table 198. Sanyou Biopharmaceuticals Co., Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 199. Sanyou Biopharmaceuticals Co., Ltd. Main Business
Table 200. Sanyou Biopharmaceuticals Co., Ltd. Latest Developments
Table 201. Biointron Biological Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 202. Biointron Biological Inc. Custom Antibody Services Product Offered
Table 203. Biointron Biological Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 204. Biointron Biological Inc. Main Business
Table 205. Biointron Biological Inc. Latest Developments
Table 206. Novoprotein Scientific Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 207. Novoprotein Scientific Inc. Custom Antibody Services Product Offered
Table 208. Novoprotein Scientific Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 209. Novoprotein Scientific Inc. Main Business
Table 210. Novoprotein Scientific Inc. Latest Developments
Table 211. Fapon Biotech Inc. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 212. Fapon Biotech Inc. Custom Antibody Services Product Offered
Table 213. Fapon Biotech Inc. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 214. Fapon Biotech Inc. Main Business
Table 215. Fapon Biotech Inc. Latest Developments
Table 216. WuXi Biologics Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 217. WuXi Biologics Custom Antibody Services Product Offered
Table 218. WuXi Biologics Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 219. WuXi Biologics Main Business
Table 220. WuXi Biologics Latest Developments
Table 221. Wuhan Boster Biological Technology Co., Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 222. Wuhan Boster Biological Technology Co., Ltd. Custom Antibody Services Product Offered
Table 223. Wuhan Boster Biological Technology Co., Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 224. Wuhan Boster Biological Technology Co., Ltd. Main Business
Table 225. Wuhan Boster Biological Technology Co., Ltd. Latest Developments
Table 226. GL Biochem Shanghai Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 227. GL Biochem Shanghai Ltd. Custom Antibody Services Product Offered
Table 228. GL Biochem Shanghai Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 229. GL Biochem Shanghai Ltd. Main Business
Table 230. GL Biochem Shanghai Ltd. Latest Developments
Table 231. Elabscience Biotechnology Co., Ltd. Details, Company Type, Custom Antibody Services Area Served and Its Competitors
Table 232. Elabscience Biotechnology Co., Ltd. Custom Antibody Services Product Offered
Table 233. Elabscience Biotechnology Co., Ltd. Custom Antibody Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 234. Elabscience Biotechnology Co., Ltd. Main Business
Table 235. Elabscience Biotechnology Co., Ltd. Latest Developments

List of Figures
Figure 1. Custom Antibody Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Custom Antibody Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Custom Antibody Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Custom Antibody Services Sales Market Share by Country/Region (2025)
Figure 8. Custom Antibody Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Custom Antibody Services Market Size Market Share by Type in 2025
Figure 10. Global Custom Antibody Services Market Size Market Share by Antibody Type in 2025
Figure 11. Global Custom Antibody Services Market Size Market Share by End User in 2025
Figure 12. Custom Antibody Services in Research Applications
Figure 13. Global Custom Antibody Services Market: Research Applications (2021-2026) & ($ millions)
Figure 14. Custom Antibody Services in In Vitro Diagnostic Applications
Figure 15. Global Custom Antibody Services Market: In Vitro Diagnostic Applications (2021-2026) & ($ millions)
Figure 16. Custom Antibody Services in Therapeutic Antibody Development
Figure 17. Global Custom Antibody Services Market: Therapeutic Antibody Development (2021-2026) & ($ millions)
Figure 18. Custom Antibody Services in Others
Figure 19. Global Custom Antibody Services Market: Others (2021-2026) & ($ millions)
Figure 20. Global Custom Antibody Services Market Size Market Share by Application in 2025
Figure 21. Global Custom Antibody Services Revenue Market Share by Player in 2025
Figure 22. Global Custom Antibody Services Market Size Market Share by Region (2021-2026)
Figure 23. Americas Custom Antibody Services Market Size 2021-2026 ($ millions)
Figure 24. APAC Custom Antibody Services Market Size 2021-2026 ($ millions)
Figure 25. Europe Custom Antibody Services Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Custom Antibody Services Market Size 2021-2026 ($ millions)
Figure 27. Americas Custom Antibody Services Value Market Share by Country in 2025
Figure 28. United States Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Custom Antibody Services Market Size Market Share by Region in 2025
Figure 33. APAC Custom Antibody Services Market Size Market Share by Type (2021-2026)
Figure 34. APAC Custom Antibody Services Market Size Market Share by Application (2021-2026)
Figure 35. China Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 39. India Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Custom Antibody Services Market Size Market Share by Country in 2025
Figure 42. Europe Custom Antibody Services Market Size Market Share by Type (2021-2026)
Figure 43. Europe Custom Antibody Services Market Size Market Share by Application (2021-2026)
Figure 44. Germany Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 45. France Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Custom Antibody Services Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Custom Antibody Services Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Custom Antibody Services Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Custom Antibody Services Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 58. APAC Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 59. Europe Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 61. United States Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 62. Canada Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 63. Mexico Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 64. Brazil Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 65. China Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 66. Japan Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 67. Korea Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 69. India Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 70. Australia Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 71. Germany Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 72. France Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 73. UK Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 74. Italy Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 75. Russia Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 76. Egypt Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 77. South Africa Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 78. Israel Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 79. Turkey Custom Antibody Services Market Size 2027-2032 ($ millions)
Figure 80. Global Custom Antibody Services Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Custom Antibody Services Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Custom Antibody Services Market Size 2027-2032 ($ millions)